Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Apr 15, 2006 (Vol. 26, No. 8)

PRIDE Home Page

URL:www.ebi.ac.uk/pride
  • Technical database
  • Needs more information interface
PRIDE (PRoteomics IDEntification database) is a project at the EMBL-Ebi that provides a common data-exchange format and repository supporting proteomics literature publications. It supports identification via both LC-MS and gel analyses. Post-translational modifications too are considered and collected. Access to the information is free and does not require log-in. Information retrieved can be downloaded or viewed in a Web browser. Searches may be performed by accession number, author/title, or experimental accession number. The interface is simple, though perhaps a bit sparse. Also, the designers could have built in a bit more description of how to search the database and what is available. As it is, the site appears to be aimed at the cognoscenti.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »